[Principles and risks of drug treatment of pain].
D000632:Aminopyrine / Q000627:therapeutic use; D000700:Analgesics / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000627:therapeutic use; D000983:Antipyrine / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D003061:Codeine / Q000627:therapeutic use; D003984:Dibenzazepines / Q000627:therapeutic use; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D007977:Levallorphan / Q000627:therapeutic use; D007981:Levorphanol / Q000627:therapeutic use; D008691:Methadone / Q000627:therapeutic use; D009020:Morphine / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy*; D010615:Phenacetin / Q000627:therapeutic use; D010653:Phenylbutazone / Q000627:therapeutic use; D011720:Pyrazoles / Q000627:therapeutic use; D012457:Salicylamides / Q000627:therapeutic use; D012459:Salicylates / Q000627:therapeutic use; D013451:Sulfonic Acids / Q000627:therapeutic use
D000700:Analgesics; D000928:Antidepressive Agents; D003984:Dibenzazepines; D011720:Pyrazoles; D012457:Salicylamides; D012459:Salicylates; D013451:Sulfonic Acids; D000632:Aminopyrine; D007981:Levorphanol; D007977:Levallorphan; D009020:Morphine; D010615:Phenacetin; D010653:Phenylbutazone; D007099:Imipramine; D001241:Aspirin; D000983:Antipyrine; D008691:Methadone; D003061:Codeine
Grundzüge und Risiken der medikamentösen Schmerzbehandlung.